Healthcare Focus Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Minnesota.

Press releases published on June 23, 2026

Happier At Home Opens New Senior Care Franchise Serving Lake Minnetonka Area
ProMed Pharma Announces Second Dedicated Manufacturing Suite Agreement at Niagara Lane Facility
AM Rx Announces Expanded Online Access and Insurance Support for Zepbound
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
Zealthy Launches Enhanced Weight-Loss Care Platform With Integrated Zepbound Access and Insurance Support
RoenRx Releases 2026 Weight-Loss Program Pricing and Treatment Cost Overview
Applied Biologics Announces Submission of Abstract of Single-Layer Amniotic Membrane Plus Standard of Care for Chronic Diabetic Foot Ulcers: An Updated Analysis of The Campx Trial to SAWC Fall 2026
Premier Health of America Obtains Creditor Protection Under The CCAA-Operations to Continue Without Interruption
Clever Care Health Plan Adds Veteran Medical, Economics, and Population Health Experts to Leadership Team After Reaching 51,000 Members
Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for €35,000 ($55,000 CAD based on current exchange rate) research grant to advance microbiota research in human health & disease
La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 35 000 € (55,000 $ CAD selon le taux de change actuel). L’objectif est de faire progresser l’étude …
TogetherTuesday: Arizona Nonprofit Surpasses $6 Million for Childhood Blindness Research
Dynacare Launches Canada's First At-Home, Self-Collect Hormone Blood Tests
PCCA Partners with TJM Labs to Bring AI Automation  to Compounding Pharmacies
GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma
GENFIT : Données positives de Phase 1b obtenues avec GNS561 en combinaison, dans une population de patients atteints de cholangiocarcinome lourdement prétraités
RESTEM to Present at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
SK pharmteco kündigt SKyvec™ an: eine integrierte virale Vektorplattform mit hoher Ausbeute zur Beschleunigung der Gentherapie-Entwicklung vom Labor bis zum Patienten
SK pharmteco lance SKyvec™, une plateforme unifiée de vecteurs viraux à haut rendement destinée à accélérer le développement des thérapies géniques, de la fabrication au patient
SK pharmteco, 생산 단계부터 환자 치료 현장까지 유전자 치료제 개발 전주기를 지원하는 통합형 고수율 바이럴 벡터 플랫폼 SKyvec™ 출시

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Focus Minnesota

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.